Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

The Nasdaq Biotechnology Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market ...

The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® ...

Alvotech ( (ALVO) ) just unveiled an announcement.

Shares of Altimmune, Inc. climbed early on Thursday, recovering from a nearly 6% drop in the previous session, drawing ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to ...

today announced its upcoming addition to the Nasdaq Biotechnology Index (Nasdaq: NBI) as part of the annual reconstitution of the 2024 Nasdaq index. Mesoblast’s inclusion in the NBI will be effective ...

has been selected to join the Nasdaq Biotechnology Index (NBI). The inclusion will be effective from the start of trading on December 23, 2024. The company, currently valued at approximately $530 ...

Spyre Therapeutics (SYRE) announced Spyre has been added to the Nasdaq Biotechnology Index effective prior to market open, Monday, December 23.

today announced that it will be added to the Nasdaq Biotechnology Index (NBI), effective at market open on Monday, December 23, 2024. “2024 has been a transformational year for MindMed.

The Nasdaq Biotechnology Index is reconstituted once a year and includes companies that meet certain financial criteria, providing a benchmark for investors interested in the biotech and ...